Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
desmopressin (ddavp) (1 trial)
tranexamic acid (cyklokapron) (1 trial)
Blood Coagulation Disorders (Phase 4)
Hemophilia A (Phase 4)
Hemostatic Disorders (Phase 4)
Menorrhagia (Phase 4)
Trials (2 total)
Trial APIs (2 total)